Virus-specific cytotoxic T lymphocytes (CTLs) are considered to be important in protection against and recovery from viral infections. In this study, several approaches to induce cytotoxicity against bovine herpesvirus 1 (BHV-1) were evaluated. Vaccination of C57BL/6 mice with BHV-1 induced a strong humoral, but no CTL, response, which may be due to downregulation of major histocompatibility complex class I molecules. In contrast, vaccinia virus expressing glycoprotein B (gB) elicited a weaker antibody response, but strong cytotoxicity, in mice. As an approach to inducing both strong humoral and cellular immune responses, a plasmid vector was then used to express gB. Both antibody and CTL responses were induced by the plasmid encoding gB in C57BL/6 and C3H mice, regardless of the type of vector backbone. This demonstrated that DNA immunization induces a broad-based immune response to BHV-1 gB. Interestingly, removal of the membrane anchor, which resulted in secretion of gB from transfected cells, did not result in reduced cytotoxicity. Here, it is shown that, compared with the cell-associated counterpart, plasmid-encoded secreted protein may induce enhanced immune responses in cattle. Therefore, calves were immunized intradermally with pMASIAtgB, a plasmid encoding the secreted form of gB (tgB), using a needle-free injection system. This demonstrated that pMASIAtgB elicited both humoral responses and activated gamma interferon-secreting CD8 + CTLs, suggesting that a DNA vaccine expressing tgB induces a CTL response in the natural host of BHV-1.
INTRODUCTIONBovine herpesvirus type 1 (BHV-1) is associated with a variety of clinical syndromes in cattle, including respiratory, genital, nervous and multisystemic infections (Wyler et al., 1989). Rhinotracheitis is often followed by secondary bacterial infections, which lead to high morbidity and mortality (Griebel et al., 1990;Yates, 1982). BHV-1 uses a variety of mechanisms to elude the host's immune system. By spreading intracellularly, it can exist in the presence of virusspecific antibodies (Fuller & Lee, 1992; Kühn et al., 1990;Miethke et al., 1995). Furthermore, depressed cell-mediated immune responses have been observed as a result of BHV-1 infection (Eskra & Splitter, 1997). Attempts to stimulate activated T cells with live BHV-1 have resulted in cell death (Griebel et al., 1990). Recent studies have shown that proteins produced by BHV-1 interfere with major histocompatibility complex (MHC) class I-mediated antigen presentation, which results in the prevention of cytotoxic T-lymphocyte (CTL) activity (Hariharan et al., 1993;Nataraj et al., 1997). Nevertheless, CTL epitopes have been identified for BHV-1, in both H-2 d and H-2 k mice (Zatechka et al., 1999).Conventional attenuated and inactivated BHV-1 vaccines do not efficiently prevent the transmission of BHV-1 or the establishment of latency, although they may protect individual animals against clinical disease. Furthermore, live-attenuated vaccines are not entirely safe, because they may cause abortions and...